The effects of enrofloxacin on canine tendon cells and chondrocytes proliferation in vitro

Veterinary Research Communications

Volumn 32, Issue 3, 2008, Pages 243-253

  Lim, S ^a   Hossain, M A ^a,b   Park, J ^a   Choi, S H ^a   Kim, G ^a  

^a Chungbuk National University   (South Korea)

^b Chittagong Government Veterinary College   (Bangladesh)

Author keywords

Apoptosis; Canine tendon cells; Cell proliferation; Chondrocytes; Enrofloxacin

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXYANILIDE INNER SALT; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ANILIDE; DNA FRAGMENT; ENROFLOXACIN; UNCLASSIFIED DRUG;

ACHILLES TENDON; ANIMAL CELL; APOPTOSIS; ARTICLE; CARTILAGE CELL; CARTILAGE INJURY; CELL GROWTH; CELL PROLIFERATION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CLEAVAGE; DOG; DOSE TIME EFFECT RELATION; IN VITRO STUDY; MITOSIS INHIBITION; MUSCLE CELL; NONHUMAN; TENDINITIS;

ACHILLES TENDON; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARTILAGE DISEASES; CELL PROLIFERATION; CHONDROCYTES; DNA FRAGMENTATION; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROQUINOLONES; TENDINOPATHY; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 38649096652     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-007-9024-8     Document Type: Article

References (31)

1. Beluche, L. A., Bertone, A. L., Anderson, D. E., Kohn, C. W. and Weisbrode, S. E., 1999. In vitro dose-dependent effects of enrofloxacin on equine articular cartilage. American Journal of Veterinary Research, 60, 577-583.
2. Corps, A. N., Harrall, R. L., Curry, V. A., Fenwick, S. A., Hazleman, B. L and Riley, G. P., 2002. Ciprofloxacin enhances the stimulation of Matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis and Rheumatism, 46, 3034-3040.
3. Davenport, C. L., Boston, R. C. and Richardson, D. W., 2001. Effects of enrofloxacin and magnesium deficiency on matrix metabolism in equine articular cartilage. American Journal of Veterinary Research, 62, 160-166.
4. Eastman, A. and Barry, M. A., 1992. The origins of DNA breaks: A consequesnce of DNA damage, DNA repair or apoptosis? Cancer Investigation, 10, 229-240.
5. Egerbacher, M., Edinger, J. and Tschulenk, W., 2001. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. American Journal of Veterinary Research, 62, 704-708.
6. Greene, C. E. and Budsberg, S. G., 1993. Veterinary use of quinolones. In Hooper D. C. and Wolfson, J. S. (eds): Quinolone antimicrobial agents, 2nd edn. pp. 473-488. Washington, DC: American Society for Microbiology, 1993.
7. Haddow, L. J., Chandra Sekhar, M., Hajela, V. and Gopal Rao, G., 2003. Spontaneous Achilles tendon rupture in patients treated with levofloxacin. Journal of Antimicrobial Chemotherapy (London), 51, 747-748.
8. Hunziker, E. B., 1999. Biologic repair of articular cartilage. Defect models in experimental animals and matrix requirements. Clinical Orthopaedics and related Research, 367, 135-146.
9. Kashida, Y. and Kato, M., 1997. Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: Comparism of toxicities of 10 fluoroquinolones and the effects of anti-inflammatory compounds. Antimicrobial Agents Chemotherapy, 41, 2389-2393.
10. Kato, M., Takada, S., Kashida, Y. and Nomura, M., 1995. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicologic Pathology, 23, 385-392.
11. Khaliq, Y. and Zhanel, G. G., 2003. Fluoroquinolone-associated tendinopathy: A critical review of the literature. Clinical Infectious Diseases, 36, 1404-1410.
12. Le Huec, J. C., Schaeverbeke, T., Chauveaux, D., Rivel, J., Dehais, J. and LeRebeller, A. 1995. Epicondylitis after treatment with fluoroquinolone antibiotics. Journal of Bone Joint Surgery. British (London), 77, 293-295.
13. Lewis, J. R., Gums, J. G. and Dickensheets, D. L., 1999. Levofloxacin-induced bilateral Achilles tendonitis. Annals of Pharmacotherapy, 33, 792-795.
14. Lipsky, B. A. and Baker, C. A., 1999. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clinical Infectious Diseases, 28, 352-364.
15. O'Driscoll, S. W., 1998. The healing and regeneration of articular cartilage. Journal of Bone Joint Surgery. America (Boston MA), 80, 1795-1812.
16. Owens, R. C. Jr. and Ambrose, P. G., 2005. Antimicrocrobial safety: focus on fluoroquinolones: Focus on fluoroquinolones. Clinical Infectious Diseases, 15, 144-157.
17. Pouzaud, F., Bernard-Beaubois, K., Thevenin, M., Warnet, J. M., Hayem, G. and Rat, P., 2004. In vitro discrimination of fluoroquinolones toxicity on tendon cells; Involvement of oxidative stress. Journal of Pharmacology and Experimental Therapeutics, 308, 394-402.
18. Riley, G. P., Curry, V., DeGroot, J., van El, B., Verzijl, N., Hazleman, B. L. and Bank, R. A., 2002. Matrix metalloproteinase activities and their relationship with collagen remodeling in tendon pathology. Matrix Biology, 21, 185-195.
19. Sendzik, J., Shakibaei, M., Schafer-Korting, M. and Stahlmann, R., 2005. Fluoroquinolones cause changes in extracellular matrix, signaling proteins, metalloproteinase and caspase-3 in cultured human tendons cells. Toxicology, 212, 24-36.
20. Shakibaei, M. and Stahlmann, R., 2001. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Archives of Toxicology, 75, 97-102.
21. Stahlmann, R. and Lode, H., 1999. Toxicity of quinolones. Drugs, 58, 37-42.
22. Stahlmann, R., Kuhner, S., Shakibaei, M., Schwabe, R., Flores, J., Evander, S. A. and van Sickle, D. C., 2000. Chondrotoxicity of ciprofloxacin in mature beagle dogs: Immunohistochemistry, electron microscopy and drug plasma concentrations. Archives of Toxicology, 73, 564-572.
23. Stewart, M. C., Saunders, K. M., Burton-Wurster, N. and Macleod, J. N., 2000. Phenotypic stability of articular chondrocytes in vitro: The effects of culture models, bone morphogenetic protein 2, and serum supplementation. Journal of Bone Mineral Research, 15, 166-174.
24. Van der Linden, P. D., van de Lei, J., Nab, H. W., Knol, A. and Stricker, B. H., 1999. Achilles tendinitis associated with fluoroquinolones. British Journal of Clinical Pharmacology, 48, 433-437.
25. Van der Linden, P. D., van Puijenbroek, E. P., Feenstra J., Veld, B. A., 2001. Sturkenboom, M. C., Herings, R. M., Leufkens, H. G. and Stricker, B. H., 2001. Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneous reports in the period 1988 to 1998. Arthritis and Rheumatism, 45, 235-239.
26. Van der Linden, P. D., Sturkenboom, M. C., Herings, R. M., Leufkens, H. G. and Stricker, B. H., 2002. Fluoroquinolones and risk of Achilles tendon disorders: Case-control study. BMJ (Clinical Research education, London), 324, 1306-1307.
27. Van der Linden, P. D., Sturkenboom, M. C., Herings, R. M., Leufkens, H. M., Rowlands, S., Stricker, B. H., 2003. Increased risk of Achilles tendon rupture with quinolone antimicrobial use, especially in elderly patients taking oral corticosteroids. Archives Internal Medicine, 163, 1802-1807.
28. Williams, R. J., Attia, E., Wickiewicz, T. L. and Hannafin, J. A., 2000. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. American Journal of Sports Medicine, 28, 364-369.
29. Yoon, J. H., Brooks, R. L. Jr., Zhao, J. Z., Isaacs, D. and Halper, J., 2004a. The effects of enrofloxacin on decorin and glycosaminoglycans in avian tendon cell cultures. Archives Toxicology, 78, 599-608.
30. Yoon, J. H., Brooks, R. L. Jr., Khan, A., Pan, H., Bryan, J., Zhang, J., Budsberg, S. C., Mueller, P. O. and Halper, J., 2004b. The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells. Cell Biology Toxicology, 20, 41-54.
31. Yu, C. and Giuffre, B., 2005. Achilles tendinopathy after treatment with fluoroquinolone. Australasian Radiology, 49, 407-410.